Introducing, OncoTarget
Mikhail V. Blagosklonny(Roswell Park Comprehensive Cancer Center), Andrei V. Gudkov(Cleveland Clinic)
Cited by 0
Related Papers
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
|Aging|2010|274
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
|Proceedings of the National Academy of Sciences|2014|153
Suppression of replicative senescence by rapamycin in rodent embryonic cells
|Cell Cycle|2012|83
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
|American Journal Of Pathology|2012|81